These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 890628)
1. Adverse reactions to 1975 bivalent influenza vaccine in children. Brandon FB Can Med Assoc J; 1977 Aug; 117(4):318. PubMed ID: 890628 [No Abstract] [Full Text] [Related]
2. Adverse reactions to 1975 bivalent influenza vaccine in children. Schevill S; Marks MI Can Med Assoc J; 1977 Feb; 116(3):271-2. PubMed ID: 837303 [TBL] [Abstract][Full Text] [Related]
3. [Adverse reactions to different types of influenza vaccines]. Bernad Valles M; Núñez Mateos JC; Castillo Soria O; González Manjavacas MC; García Serna B Med Clin (Barc); 1996 Jan; 106(1):11-4. PubMed ID: 8750535 [TBL] [Abstract][Full Text] [Related]
4. Trivalent inactivated influenza vaccine safety in children: assessing the contribution of telephone encounters. Mullooly JP; Crane B; Chun C Vaccine; 2006 Mar; 24(13):2256-63. PubMed ID: 16375995 [TBL] [Abstract][Full Text] [Related]
5. Dermal testing of vaccines for children at high risk of allergies. Sugai K; Shiga A; Okada K; Iwata T; Ogura H; Maekawa K; Yokota S Vaccine; 2007 Apr; 25(17):3454-63. PubMed ID: 17276555 [TBL] [Abstract][Full Text] [Related]
6. Clinical and epidemiological evaluation of a live, cold-adapted influenza vaccine for 3-14-year-olds. Rudenko LG; Lonskaya NI; Klimov AI; Vasilieva RI; Ramirez A Bull World Health Organ; 1996; 74(1):77-84. PubMed ID: 8653819 [TBL] [Abstract][Full Text] [Related]
8. [Immediate adverse reactions after administration of the influenza vaccine to patients with positive CAP-RAST to egg white]. Kawahara H; Morisawa Y; Katunuma T; Ohya Y; Saito H; Akasawa A Arerugi; 2002 Jul; 51(7):559-64. PubMed ID: 12201169 [TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age. Belshe RB; Ambrose CS; Yi T Vaccine; 2008 Sep; 26 Suppl 4():D10-6. PubMed ID: 18611422 [TBL] [Abstract][Full Text] [Related]
10. Safe administration of an inactivated virosomal adjuvanted influenza vaccine in asthmatic children with egg allergy. Esposito S; Gasparini C; Martelli A; Zenga A; Tremolati E; Varin E; Marseglia GL; Fiocchi A; Principi N Vaccine; 2008 Aug; 26(36):4664-8. PubMed ID: 18639601 [TBL] [Abstract][Full Text] [Related]
11. [Safety of an influenza-split-vaccine in children]. Schmitt-Grohé S; Banzhoff A; Klaassen B; Zielen S Klin Padiatr; 2001; 213(6):338-42. PubMed ID: 11713714 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B; Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278 [TBL] [Abstract][Full Text] [Related]
13. Adverse reactions to simultaneous influenza and pneumococcal conjugate vaccinations in children: randomized double-blind controlled trial. Jansen AG; Sanders EA; Smulders S; Hoes AW; Hak E Pediatr Allergy Immunol; 2008 Sep; 19(6):552-8. PubMed ID: 18221474 [TBL] [Abstract][Full Text] [Related]
15. Safe vaccination of children with a virosomal adjuvanted influenza vaccine. Künzi V; Dornseiff M; Horwath J; Hartmann K Vaccine; 2009 Feb; 27(8):1261-5. PubMed ID: 19114080 [TBL] [Abstract][Full Text] [Related]
16. Live attenuated influenza vaccine in children. Ambrose CS; Walker RE; Connor EM Semin Pediatr Infect Dis; 2006 Oct; 17(4):206-12. PubMed ID: 17055372 [TBL] [Abstract][Full Text] [Related]
17. [Immunogenicity and safety of influenza split vaccine]. Dong JH; Chang WH; Tian XP Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Mar; 30(3):310-1. PubMed ID: 19642397 [No Abstract] [Full Text] [Related]
18. Acute neurological events associated with influenza vaccination: are the WHO criteria for assessing causality adequate? Kavadas FD; Bitnun A; MacGregor D; Heurter H; Ford Jones EL Scand J Infect Dis; 2008; 40(6-7):565-70. PubMed ID: 18584549 [TBL] [Abstract][Full Text] [Related]
19. A TritonX-100-split virion influenza vaccine is safe and fulfills the committee for proprietary medicinal products (CPMP) recommendations for the European Community for Immunogenicity, in Children, Adults and the Elderly. Lina B; Fletcher MA; Valette M; Saliou P; Aymard M Biologicals; 2000 Jun; 28(2):95-103. PubMed ID: 10885616 [TBL] [Abstract][Full Text] [Related]